Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Effect of Intravenous Anesthetics on Fear Learning and Memory
This study is currently recruiting participants.
Verified by Weill Medical College of Cornell University, October 2008
Sponsored by: Weill Medical College of Cornell University
Information provided by: Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00767767
  Purpose

People often develop fearful responses to things, but have no conscious control over the fear (e.g. phobias). This is a basic form of unconscious memory, called âââ€-¬Ã<Å"fear conditioningâââ€-‰"¢. Intravenous anesthetic drugs have remarkable effects on conscious memory, but it is unknown whether they have similar effects on these unconscious fear memories.

To address this question, the investigators will study 90 healthy adult volunteer subjects. The subject is given a very low dose of an anesthetic drug intravenously (i.e. through the bloodstream). The dose is so low that the subject might not even be able tell if they are getting the drug. While they are receiving the drug, the subject will perform a series of memory tests and a fear conditioning experiment, which are set up like a very simple computer game. To create the âââ€-¬Ã<Å"fear responseâââ€-‰"¢, subjects will occasionally receive a mildly uncomfortable shock to their arm. The subject is able to determine the highest level of shock that they will receive.

The investigators are doing this study because the investigators wish to know exactly how the drugs affect the way people process fear and emotion. This knowledge might one day be used in the treatment of some psychiatric disorders.


Condition Intervention
Phobias
Drug: Propofol
Drug: Placebo
Drug: Thiopental
Drug: Midazolam
Drug: Dexmedetomidine

MedlinePlus related topics: Anesthesia Memory Phobias
Drug Information available for: Midazolam Midazolam hydrochloride Midazolam maleate Propofol Dexmedetomidine Dexmedetomidine hydrochloride Thiopental Thiopental sodium
U.S. FDA Resources
Study Type: Interventional
Study Design: Basic Science, Randomized, Single Blind (Subject), Placebo Control, Parallel Assignment, Pharmacodynamics Study
Official Title: The Effect of Intravenous Anesthetics on Fear Learning and Memory

Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • Changes in skin conductance [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in the eye-blink reflex following an auditory startle probe [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]
  • Changes in heart-rate variability [ Time Frame: Throughout Study ] [ Designated as safety issue: No ]

Estimated Enrollment: 90
Study Start Date: October 2008
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Placebo Comparator
Saline Infusion.
Drug: Placebo
IV Saline infusion for 2 hours.
2: Active Comparator
Anesthetic Drug Infusion.
Drug: Propofol
IV Propofol infusion for 2 hours.
Drug: Thiopental
IV Thiopental infusion for 2 hours.
Drug: Midazolam
IV Midazolam infusion for 2 hours.
Drug: Dexmedetomidine
IV Dexmedetomidine Infusion for 2 hours.

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age between 18 and 50
  • right handed
  • minimum of high school education
  • fluent in English
  • normal vocabulary

Exclusion Criteria:

  • any significant medical or psychiatric comorbidity (e.g. asthma, diabetes, hypertension, depression, high anxiety)â€"subjects must be in excellent health such that they would be classified as American Society of Anesthesiologists Physical Status Class I
  • deficit in vision or hearing that would impede the study
  • allergies to any of the study drugs, to soybeans, or to eggs
  • a history of head trauma
  • a family history of major psychiatric illness
  • body mass index > 30 kg/m2
  • a recent history of recreational drug use
  • prior exposure to the study materials
  • pregnancy
  • a personal or family history of any porphyria
  • (xi) failure to exhibit a skin conductance response to deep inspiration; (xii) the ability to read native Chinese characters
  • assessment by the investigators that the subject may be unable to cooperate or comply with the study requirements.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00767767

Contacts
Contact: Jackie Bogan, B.A. 212-746-9419 jab2035@med.cornell.edu

Locations
United States, New York
Weill Cornell Medical College/New York Presbyterian Hospital Recruiting
New York, New York, United States, 10065
Contact: Jackie Bogan, B.A.     212-746-9419     jab2035@med.cornell.edu    
Principal Investigator: Kane Pryor, MD            
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Kane Pryor, MD Weill Cornell Medical College
  More Information

Responsible Party: Weill Cornell Medical College ( Kane Pryor )
Study ID Numbers: 0710009434
Study First Received: October 3, 2008
Last Updated: October 6, 2008
ClinicalTrials.gov Identifier: NCT00767767  
Health Authority: United States: Food and Drug Administration

Keywords provided by Weill Medical College of Cornell University:
To investigate the effects of anesthetic drugs on associative memory processes involving fear

Study placed in the following topic categories:
Thiopental
Dexmedetomidine
Propofol
Midazolam
Phobic Disorders

Additional relevant MeSH terms:
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
GABA Modulators
Physiological Effects of Drugs
Psychotropic Drugs
Anesthetics
Adrenergic Agonists
Sensory System Agents
Therapeutic Uses
Hypnotics and Sedatives
Analgesics
Anesthetics, Intravenous
Tranquilizing Agents
Adrenergic alpha-Agonists
Central Nervous System Depressants
Pharmacologic Actions
Adjuvants, Anesthesia
Anesthetics, General
Analgesics, Non-Narcotic
GABA Agents
Anti-Anxiety Agents
Peripheral Nervous System Agents
Central Nervous System Agents
Anticonvulsants

ClinicalTrials.gov processed this record on January 16, 2009